Concepedia

Rory M. Shallis

RM

Statistics

Publications

34

Citations

1.2K

H-Index

19

Active since

2015

Affiliations

Yale University(Current)

Yale Cancer Center

Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Rory M. Shallis is an author at Yale University specializing in medicine, oncology, and hematologic malignancy therapy.

ORCID

Publications per year

2015–2025

34

Publications

34

Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology

Daniel A. Pollyea, Jessica K. Altman, Rita Assi et al. · Journal of the National Comprehensive Cancer Network · 2023 · 178 citations · Full text

, , +17

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022

Peter L. Greenberg, Richard M. Stone, Aref Al‐Kali et al. · Journal of the National Comprehensive Cancer Network · 2022 · 125 citations · Full text

, , +17

Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study

Maximilian Stahl, Rory M. Shallis, Wei Wei et al. · Leukemia · 2020 · 97 citations · Full text

, , +16

Clinical outcomes of older patients with AML receiving hypomethylating agents: a large population-based study in the United States

Amer M. Zeidan, Rong Wang, Xiaoyi Wang et al. · Blood Advances · 2020 · 89 citations · Full text

, , +9

Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

Talha Badar, Ehab Atallah, Rory M. Shallis et al. · Leukemia · 2023 · 62 citations · Full text

, , +17

1–5 of 34